HOXA9 and lung carcinoma: Additionally, an assay in development, Lung EpiCheck®, which includes markers such as HOXA9, has demonstrated strong performance in detecting lung cancer, including early-stage disease, across European and Chinese high-risk populations, supporting its utility as a non-invasive screening tool [30,31,32,33].